These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 8846803)
21. Calcium antagonists in secondary prevention after myocardial infarction. Persson S Drugs; 1991; 42 Suppl 2():54-60. PubMed ID: 1718702 [TBL] [Abstract][Full Text] [Related]
22. [Comparison of the anti-angina effect of the calcium antagonists diltiazem, nifedipine and verapamil with each other and with propranolol]. Ferrero JA; Asensi JF; Madrigal JA; Haba J; Chorro FJ; López Merino V Rev Esp Cardiol; 1987; 40(4):249-55. PubMed ID: 3659517 [No Abstract] [Full Text] [Related]
23. Role of calcium antagonists in progression of arteriosclerosis. Evidence from animal experiments and clinical experience. Part II. Clinical experience with preventive effects of calcium channel blockers in atheromatous coronary artery disease. Just H; Frey M Basic Res Cardiol; 1994; 89 Suppl 1():177-84. PubMed ID: 7945172 [TBL] [Abstract][Full Text] [Related]
24. Use of calcium channel blocking agents in angina pectoris. Breland BD; Boland MJ J Miss State Med Assoc; 1984 Mar; 25(3):57-62. PubMed ID: 6371246 [No Abstract] [Full Text] [Related]
25. [Calcium antagonists in the treatment of arterial hypertension]. Chlewicka I; Wasowska T Pol Tyg Lek; 1982 Nov; 37(44):1327-9. PubMed ID: 6761674 [No Abstract] [Full Text] [Related]
28. [Stable angina pectoris: what is the role of calcium antagonists?]. Tiberti G; Bossi M G Ital Cardiol; 1997 Oct; 27(10):1062-6. PubMed ID: 9410778 [No Abstract] [Full Text] [Related]
29. [Treatment of angina pectoris with calcium antagonists]. Hopf R; Becker HJ; Kober G; Dowinsky S; Kaltenbach M Herz; 1982 Aug; 7(4):221-34. PubMed ID: 6751971 [No Abstract] [Full Text] [Related]
30. Calcium-channel blockers in vasospastic angina--a review. Ambrosio G Postgrad Med J; 1983; 59 Suppl 3():26-9. PubMed ID: 6359108 [No Abstract] [Full Text] [Related]
31. In vivo characterization of combination antitumor chemotherapy with calcium channel blockers and cis-diamminedichloroplatinum(II). Onoda JM; Nelson KK; Taylor JD; Honn KV Cancer Res; 1989 Jun; 49(11):2844-50. PubMed ID: 2720644 [TBL] [Abstract][Full Text] [Related]
32. [Calcium antagonists. Properties and current indications]. Amoroso A; Lanciotti G; Mammarella A Recenti Prog Med; 1984 Apr; 75(4):353-60. PubMed ID: 6374795 [No Abstract] [Full Text] [Related]
33. Calcium channel blockers: an evidence-based review. Waters D Can J Cardiol; 1997 Aug; 13(8):757-66. PubMed ID: 9284842 [TBL] [Abstract][Full Text] [Related]
34. Short-acting nifedipine and diltiazem do not reduce the incidence of cardiac events in patients with healed myocardial infarction. Secondary Prevention Group. Ishikawa K; Nakai S; Takenaka T; Kanamasa K; Hama J; Ogawa I; Yamamoto T; Oyaizu M; Kimura A; Yamamoto K; Yabushita H; Katori R Circulation; 1997 May; 95(10):2368-73. PubMed ID: 9170398 [TBL] [Abstract][Full Text] [Related]
35. [Calcium antagonists in angina pectoris]. Bracchetti D; Sangiorgio P; Fulvi M; Rubboli A G Ital Cardiol; 1988 Nov; 18(11):970-3. PubMed ID: 3248701 [No Abstract] [Full Text] [Related]
36. [Indications for calcium channel antagonist therapy according to the latest large clinical trials]. Kosicka T; Kara-Perz H; Głuszek J; Perz S Pol Arch Med Wewn; 2005 Dec; 114(6):1244-51. PubMed ID: 16789496 [No Abstract] [Full Text] [Related]